SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-016872
Filing Date
2022-06-10
Accepted
2022-06-10 17:26:19
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165489636547699.html 4  
1 FORM 4 wf-form4_165489636547699.xml 4 5534
  Complete submission text file 0001628280-22-016872.txt   6934
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Boyd Peter E. (Reporting) CIK: 0001739816 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 221009981